Encompass Design India Limited has incorporated a new subsidiary, The Longevity Plan Private Limited, effective July 08, 2026, to diversify its business operations into the pharmaceutical and nutraceutical industry. The strategic move aims to expand the company's current business scope by developing, marketing, and distributing nutraceuticals, dietary supplements, and health and wellness products. The subsidiary will also engage in research and development, brand development, and digital health solutions through online and offline channels.

The incorporation was completed pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, and relevant SEBI circulars. The Certificate of Incorporation was issued by the Registrar of Companies on July 08, 2026. The transaction falls under related party transactions, with the promoter group holding an interest, though it was conducted at arm's length.

The Longevity Plan Private Limited has been incorporated with an authorized capital of INR 15,00,000 and a paid-up share capital of INR 60,000. Encompass Design India Limited subscribed to 4,000 equity shares of INR 10 each at a cash consideration of INR 40,000, acquiring a 66.67% stake in the entity. The subsidiary is yet to commence business operations.

Key Details of the Subsidiary

The subsidiary's operations will focus on preventive healthcare and allied wellness services. The company has confirmed that no specific governmental or regulatory approvals were required for the incorporation, and the transaction was funded entirely through cash subscription to the share capital.

Encompass Design India Limited has confirmed that its promoters and persons acting in concert have not encumbered any shares held directly or indirectly during the year ended March 31, 2026. This disclosure ensures that the shareholding structure of the promoters remains free from pledges or other charges, which is a key indicator of financial stability for investors. The confirmation was submitted to the National Stock Exchange of India (NSE) in compliance with regulatory requirements.

The filing was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation mandates annual disclosures by promoters regarding any encumbrance over their shareholdings. The document was signed by Amit Rajendraprasad Dalmia, Managing Director & Promoter, on behalf of himself, the Promoter, and the Promoter Group.

Disclosure Details

The submission formally declares that no shares were pledged or otherwise encumbered by the promoters or those acting in concert throughout the financial year. The disclosure was addressed to the Listing Compliance and Corporate Relationship Departments of the NSE.